Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 5, Number 8

Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Revaccination of tuberculin-negative schoolchildren is a regular practice in Hong Kong.

OBJECTIVE: To assess the efficacy of BCG revaccination guided by tuberculin skin testing.

METHOD: A cohort of 303692 children vaccinated at birth was followed through the tuberculosis notification register for the development of active disease. The percentage of cohort who participated in the BCG revaccination program during primary school was estimated from the vaccination statistics of the Hong Kong Department of Health. The BCG revaccination history of identified cases was ascertained through vaccination cards and clinic records.

RESULTS: A total of 85.2% of the cohort participated in the BCG revaccination programme; 79.7% of the participants were tuberculin-negative and revaccinated; 343 developed tuberculosis after the age of 11; 302 were among the participants in the programme while 41 were not. The tuberculosis incidence was 16.5 and 12.9 per 100000 person-years for participants and non-participants, respectively (RR 1.28, 95%CI 0.92–1.77). Among the participants, tuberculosis incidence was 12.5 and 32.0/100000 person-years, respectively, for the tuberculin-negative/BCG revaccinated group and the tuberculin-positive/non-revaccinated group (RR 0.39, 95%CI 0.31–0.49).

CONCLUSION: This study failed to demonstrate any significant difference in the incidence rates of tuberculosis among participants and non-participants in a school BCG revaccination programme. The increased risk for tuberculosis in the tuberculin-positive group does not support the use of the tuberculin testing for detection of immunity conferred by neonatal BCG vaccination.

Keywords: BCG; efficacy; revaccination; tuberculin

Document Type: Regular Paper

Affiliations: 1: TB and Chest Service, Department of Health, Hong Kong SAR, China 2: Department of Medicine, The University of Hong Kong, Hong Kong SAR, China

Publication date: 01 August 2001

More about this publication?

  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content